Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C

Lam, 1997, Hepatology, 26, 226, 10.1002/hep.510260130 Neumann, 1998, Science, 282, 103, 10.1126/science.282.5386.103 Zeuzem, 1996, Hepatology, 23, 366 Neumann, 2000, J Infect Dis, 182, 28, 10.1086/315661 Zeuzem, 2001, Hepatology, 120, 1438 Layden, 2001, Gastroenterology, 120, 1546, 10.1053/gast.2001.24401 Manns, 2001, Lancet, 358, 958, 10.1016/S0140-6736(01)06102-5 Knodell, 1981, Hepatology, 5, 431, 10.1002/hep.1840010511 Tong, 1994, J Gastroenterol Hepatol, 9, 587, 10.1111/j.1440-1746.1994.tb01566.x Stuyver, 1993, J Gen Virol, 74, 1093, 10.1099/0022-1317-74-6-1093 Paterson, 2000, Ann Intern Med, 133, 21, 10.7326/0003-4819-133-1-200007040-00004 McHutchison, 2002, Gastroenterology, 123, 1061, 10.1053/gast.2002.35950 Hadziyannis, 2002, J Hepatol, 37, 536a, 10.1016/S0168-8278(02)00240-4 Rebetol summary of product characteristics. The European Agency for the Evaluation of Medicinal Products. Available at: www.emea.eu.int/humandocs/PDFs/EPAR/Rebetol/087199en4.pdf. McHutchison, 1998, N Engl J Med, 339, 1485, 10.1056/NEJM199811193392101 Poynard, 1998, Lancet, 352, 1426, 10.1016/S0140-6736(98)07124-4 Davis, 1989, N Engl J Med, 321, 1501, 10.1056/NEJM198911303212203 Fukutomi, 2001, J Hepatol, 34, 100, 10.1016/S0168-8278(00)00044-1 Bekkering, 2001, Hepatology, 33, 419, 10.1053/jhep.2001.21552 Layden, 2002, J Viral Hepat, 9, 340, 10.1046/j.1365-2893.2002.00377.x Nolte, 2001, J Clin Microbiol, 39, 4005, 10.1128/JCM.39.11.4005-4012.2001 Pockros, 1999, J Viral Hepat, 6, 145, 10.1046/j.1365-2893.1999.00147.x Davis, 1994, Hepatology, 19, 1337, 10.1002/hep.1840190603 Poynard, 2000, Hepatology, 32, 1131, 10.1053/jhep.2000.19347 Shiffman, 2000, Am J Gastroenterol, 95, 2928, 10.1111/j.1572-0241.2000.02321.x Everson, 2000, Hepatology, 32, 436, 10.1053/jhep.2000.16216 Fattovich, 1997, J Hepatol, 27, 201, 10.1016/S0168-8278(97)80302-9 Fattovich, 2002, Hepatology, 36, 792, 10.1002/hep.510360403 National Institutes of Health Consensus Development, 2002, Hepatology, 36, s3 Davis, 2002, Hepatology, 36, s145 Fried, 2002, N Engl J Med, 347, 975, 10.1056/NEJMoa020047